ROVI swings to H1 net profit of EUR 84.38 million; net sales rise 9.4% to EUR 344.16 million

Reuters2026/07/23 05:38

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Laboratorios Farmacéuticos ROVI posted H1 net profit attributable to shareholders of EUR 84.48 million, turning from a loss a year earlier.
Net sales rose to EUR 344.16 million, while operating income climbed to EUR 103.13 million.
Basic EPS increased to EUR 1.65.
Cash and cash equivalents rose to EUR 126.97 million at June 30, while total assets increased to EUR 1.13 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laboratorios Farmacéuticos ROVI SA published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ROVI swings to H1 net profit of EUR 84.38 million; net sales rise 9.4% to EUR 344.16 million

You may also like

Crypto prices